Clinical Trials Browser

Phase 2 × Skin Neoplasms × Dasatinib × Clear all

NCT00563290 2015-06-18

Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia

Phase 2 Completed

7 enrolled 6 charts

DermatologicLymphoidOther hematologic neoplasm

Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell